Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture (GRASP-DC)

Endo Pharmaceuticals

Status: Terminated

Conditions: Dupuytren's Contracture

Study type: Observational

Funder types: Industry; Other

Identifiers

NCT05877066

EP01REG

Details and patient eligibility

About

This is an observational study, meaning participants will not receive any investigational treatment as part of this study.

Researchers will collect real-world data (RWD), based on usual care, to gain a more in-depth knowledge of the natural history and the treatment outcomes of Dupuytren's Contracture (DC) to evaluate the management of DC.

Full description

Each participant of the study will have their data collected from the date of confirmed diagnosis of DC to the date of enrollment in the registry, post consent. Data will be collected from the participants clinical records as well as from the participant directly. Data will be collected through Pulse Infoframe's technology platform.

Enrollment: 130 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

• Any adult with a confirmed clinical diagnosis of DC.
• Age 18 years (or age of majority in their jurisdiction) or older at time of enrollment.
• Willing to participate in the registry (including completion of ePROs) and complete the informed consent form.
• Having received DC treatment, either non-surgical or surgical, within 2 weeks before enrollment, at enrollment or any time after the date of enrollment or not having received DC treatment after confirmed diagnosis of DC.
• Able to participate in English based registry.

Key Exclusion criteria:

• Not having a clinical diagnosis of DC.
• Age less than 18 years.
• Do not provide informed consent.